[Giving a future to clinical (urologic) research in France. Point of view of the medical director in the pharmaceutical industry].
The regulation of clinical research in France is aimed essentially at the protection of individuals and the maintenance of good clinical practice. However, in an international context, certain obstacles linked to this regulation, as well as other obstacles of a financial and organisational nature, limit the participation of the French investigational centers, particularly in private clinical research. Legal texts and practical concerns are considered in this light; solutions are outlined.
Loeb
G
G
Yamanouchi Pharma, 10, place de la Coupole, BP 105, 94223 Charenton le Pont. loeb.gerard@yamanouchi.fr
D004345:Drug Industry; D005544:Forecasting; D005602:France; D012106:Research / Q000458:organization & administration / Q000639:trends*; D012456:Salaries and Fringe Benefits; D014572:Urology / Q000458:organization & administration